RayzeBio inc (DELISTED) (RYZB:DL)
62.49
0.00 (0.00%)
USD |
NASDAQ |
Mar 06, 16:00
RayzeBio Shareholders Equity (Quarterly): 575.32M for Sept. 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 575.32M |
June 30, 2023 | -135.49M |
Date | Value |
---|---|
December 31, 2022 | -111.29M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-135.49M
Minimum
Jun 2023
575.32M
Maximum
Sep 2023
109.51M
Average
-111.29M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
Bristol-Myers Squibb Co | 16.49B |
Karuna Therapeutics Inc (DELISTED) | 1.254B |
Ambrx Biopharma Inc (DELISTED) | 242.40M |
Pfizer Inc | 92.28B |
Mirati Therapeutics Inc (DELISTED) | 946.46M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 603.51M |
Total Liabilities (Quarterly) | 28.19M |